Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae , and Pseudomonas aeruginosa From US Hospitals by Sutherland, Christina A., BS, Nicolau, David P., PharmD

Get full text

Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women by Swank, Morgan L., MD, Wing, Deborah A., MD, Nicolau, David P., PharmD, McNulty, Jennifer A., MD

Get full text

Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration by Avery, Lindsay M., PharmD, Chen, Iris H., PharmD, Reyes, Sergio, MD, Nicolau, David P., PharmD, FCCP, FIDSA, Kuti, Joseph L., PharmD, FIDP

Get full text

A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Re... by Asempa, Tomefa E., PharmD, Kuti, Joseph L., PharmD, FIDP, Seroogy, Julie D., BS, Komirenko, Allison S., PharmD, Nicolau, David P., PharmD, FCCP, FIDSA

Get full text

A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy by Lakshmipathy, Damini, Ye, Xiaoyi, Kuti, Joseph L, Nicolau, David P, Asempa, Tomefa E

Get full text

Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia by Kim, Aryun, PharmD, Kuti, Joseph L., PharmD, Nicolau, David P., PharmD

Get full text

When Pharmacodynamics Trump Costs: An Antimicrobial Stewardship Program’s Approach to Selecting Optimal Antimicrobial Agents by Goff, Debra A., PharmD, FCCP, Nicolau, David P., PharmD, FCCP, FIDSA

Get full text

Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia by Nicasio, Anthony M., PharmD, Eagye, Kathryn J., MPH, Nicolau, David P., PharmD, FCCP, FIDSA, Shore, Eric, MD, Palter, Marc, MD, Pepe, Judith, MD, Kuti, Joseph L., PharmD

Get full text

Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae by Kontou, Paschalina, MD, Kuti, Joseph L., PharmD, Nicolau, David P., PharmD

Get full text

In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals by Eagye, Kathryn J., MPH, Kuti, Joseph L., PharmD, Sutherland, Christina A., BS, Christensen, Henry, BS, Nicolau, David P., PharmD, FCCP, FIDSA

Get full text

Optimal cefepime and meropenem dosing for ventilator-associated pneumonia patients with reduced renal function: An update to our clinical pathway by Kuti, Joseph L., PharmD, Nicolau, David P., PharmD, FCCP, FIDSA

Get full text

Empiric therapy for secondary peritonitis: A pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using... by Eagye, Kathryn J., MPH, Kuti, Joseph L., PharmD, Dowzicky, Michael, MS, Nicolau, David P., PharmD, FCCP

Get full text

Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia by Villegas, Maria Virginia, Briceno, David Felipe, Ruiz, Sory Jamil, Furtado, Guilherme H., Nicolau, David P.

Get full text